Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 9, 2013, Pages 6150-6157

  Choi, Jaewan ^a   Lee, Jong Rak ^b   Lee, Youngrok ^b   Lee, Kyoung Sub ^b   Na, Jung Hwa ^b   Han, Seungbong ^b   Kook, Michael Scott ^b  

^a Seoul Shinsegae Eye Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Mean ocular perfusion pressure fluctuation; Ocular perfusion pressure; Open angle glaucoma; Paracentral visual field progression rate

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DORZOLAMIDE PLUS TIMOLOL; PROSTAGLANDIN DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE; CENTRAL CORNEAL THICKNESS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; MEAN OCULAR PERFUSION PRESSURE; OCULOPLETHYSMOGRAPHY; OPHTHALMOSCOPY; PERIMETRY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL SYSTEM PARAMETERS;

MEAN OCULAR PERFUSION PRESSURE FLUCTUATION; OCULAR PERFUSION PRESSURE; OPEN-ANGLE GLAUCOMA; PARACENTRAL VISUAL FIELD PROGRESSION RATE;

ADULT; AGED; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSORY THRESHOLDS; TIME FACTORS; VISUAL FIELDS;

EID: 84883872170     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12093     Document Type: Article

References (37)

1. Burr JM, Kilonzo M, Vale L, Ryan M. Developing a preferencebased Glaucoma Utility Index using a discrete choice experiment. Optom Vis Sci. 2007;84:797-808.
2. Aspinall PA, Johnson ZK, Azuara-Blanco A, Montarzino A, Brice R, Vickers A. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49: 1907-1915.
3. Park SC, De Moraes CG, Teng CCW, et al. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology. 2011;118:1782-1789.
4. Park HYL, Jung KI, Na KS, et al. Visual field characteristics in normal-tension glaucoma patients with autonomic dysfunction and abnormal peripheral microcirculation. Am J Ophthalmol. 2012;154:466-475.
5. Choi J, Jeong J, Cho HS, et al. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006;47:831-836.
6. Choi J, Kim KH, Jeong J, et al. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normaltension glaucoma. Invest Ophthalmol Vis Sci. 2007;48:104-111.
7. Sung KR, Lee S, Park SB, et al. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci. 2009;50: 5266-5274.
8. Sung KR, Cho JW, Lee S, et al. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2011;52:737-743.
9. Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol. 2004;43:S5-S9.
10. Sherwood L. Human Physiology: From Cells to Systems. 5th ed. Pacific Grove, CA: Brooks Cole; 2004.
11. Gherghel D, Orgul S, Gugleta K, et al. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol. 2000;130:597-605.
12. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it: myth and reality. Prog Retin Eye Res. 2001;20: 563-593.
13. Bisantis C. Ocular blood flow and its autoregulation. In: Bucci MG ed. Glaucoma: Decision Making in Therapy. Milan: Springer-Verlag; 1996:37-40.
14. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study. Ophthalmology. 2004;111:1627-1635.
15. Caprioli J. Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmology. 2007;125: 1124-1125.
16. De Moraes CG, Prata TS, Tello C, Ritch R, Liebmann JM. Glaucoma with early visual field loss affecting both hemi-fields and the risk of disease progression. Arch Ophthalmol. 2009; 127:1129-1134.
17. Cho HK, Kee C. Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients. Am J Ophthalmol. 2012;154:958-968.
18. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
19. Katz J, Gilbert D, Quigley HA, Sommer A. Estimation progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017-1025.
20. Shigeeda T, Tomidokoro A, Araie M, et al. Long-term follow-up of visual field progression after trabeculectomy in progressive normal-tension glaucoma. Ophthalmology. 2002;109:766-770.
21. Fukuchi T, Yoshino T, Sawada H, et al. Progression rate of total, and upper and lower visual field defects in open-angle glaucoma patients. Clin Ophthalmol. 2010;4:1315-1323.
22. Teng CC, De Moraes CG, Prata TS, et al. The region of largest beta-zone parapapillary atrophy area predicts the location of most rapid visual field progression. Ophthalmology. 2011;118: 2409-2413.
23. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999;213:76-96.
24. Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol. 2005;123:1554-1562.
25. Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol. 1998;236:188-192.
26. Ellenberger C Jr, Netsky MG. Infarction in the optic nerve. J Neurol Neurosurg Psychiatry. 1968;31:606-611.
27. Mikelberg FS, Drance SM. The mode of progression of visual field defects in glaucoma. Am J Ophthalmol. 1984;98:443-445.
28. Boden C, Blumenthal EZ, Pascual J, et al. Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol. 2004;138:1029-1036.
29. Chen PP. Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology. 2002; 109:2093-2099.
30. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114:1965-1972.
31. Chen PP, Park RJ. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology. 2000;107:1688-1692.
32. Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44:1586-1590.
33. Hara T, Tsuru T. Increase of peak intraocular pressure during sleep in reproduced diurnal changes by posture. Arch Ophthalmol. 2006;124:165-168.
34. Lee YR, Kook MS, Joe SG, et al. Circadian (24-hour) pattern of intraocular pressure and visual field damage in eyes with normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2012;53: 881-887.
35. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol. 1987;105:1544-1549.
36. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108:130-135.
37. Katz J, Sommer A. A longitudinal study of the age-adjusted variability of automated visual fields. Arch Ophthalmol. 1987; 105:1083-1086.